FAM83A

Across TCGA pan-cancer cohorts, FAM83A mass-spec protein differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of FAM83A’s most consistent transcriptional readouts.

The strongest signal is observed in lung squamous cell carcinoma (LSCC), where FAM83A mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types FAM83A is over-expressed in tumor.

LSCC, HNSC, and PDAC are the cancer types where FAM83A tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in FAM83A mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LSCC	All	II,III,IV	+0.739	<.001	7	view →
HNSC	All	II,III,IV	+0.522	<.001	6	view →
PDAC	All	III,IV	+1.512	.009	5	view →
LUAD	Male	All	+0.453	<.001	5	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

FAM83A–LSCC

Open the LSCC breakdown →